ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Bridge Biotherapeutics Announces FDA IND Clearance for BBT-176, an EGFR TKI for NSCLC
January 20, 2020Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea, announced that the Investigational New Drug (IND) application submitted to the U.S. Food and Drug Administration (FDA) has been cleared on January
Pharma Sources Insight January 2025
